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Among lymphoreticular cell s, Langerhans cells and splenic 
dendritic cells stand alone in their ca pacity, when hapten-
d e rivati zed, to induce vigorous immune responses, irre-
sp ective of route of inoculation , includin g intravenous . We 
h ave examined the comparative effi ciency of relatively pu-
rified popul ations of Langerhans cells and their epidermal 
companions, keratinocytes, to induce alloimmunity when 
injected intravenously into adult mice. It was found that 
as few as 100 BALBI c Langerhans cel ls inj ected intrave-
L angerhans cells, bone m arrow derived dend ritic cells that reside in the supra bas ilar pl ane of the epidermis, are rega rded as definitiv e antigen presentin g cells w ithin th e skin [1-3] , although other cells, such as derma l m acro phages, ma y also function in this manner wi thin 
the cutaneous en vironment [1-5]. Amon g epidermal cells , Lan g-
erhans cells are the most efficient in vitro at stimulatin g allogeneic 
ly mphocytes in th e mixed lymphocy te- epidermal cell response, 
and at presentin g nomin al antigens to specifi ca ll y primed T lym-
phocytes [1 ,3, 6J. Similarl y, cutaneo us surfaces containing no rmal 
numbers of fun ction al Lan gerhans cells support the inductio n of 
hapten-specific contac t hy persensitivity whereas Langerhans cell-
deficient or cell-depleted surfaces fail to support sensitiza tion [2, 7,8]. 
FuU thi ckness gra fts prepared from no rm al m ouse co rn eas (which 
lack Langerh ans cells) and placed heterotopica ll y fa il to sensitize 
recipient mice to C lass II major histoco mpatibility antigens (MHC); 
by contras t, corn ea grafts into which Langerhans cells ha ve been 
induced to mi grate prove readil y ca pable of immunizing to C lass 
II MHC m o lecules [9, 10]. Since no rmal co rneal grafts are able to 
sen sitize appropriate recipients to C lass I MHC allodeterminants, 
other constitutive cells , (presum ably keratinocytes) , can evoke 
sensiti za ti on in the absence of Langerhans cells [9] . Thus , Lang-
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Abbreviations: 
EC: epiderm al cells 
FACS: flu orescence-acti va ted cell sorter 
FCS: feta l calf serum 
HBSS: Hanks' balanced salt solu tion 
MHC: major histocompatibility complex 
MST: med ian survival time 
PBS: phosphate-buffered saline 
nously into C3H mice are capa ble of inducing specifi c sen-
sitiza tion as evidenced by su bsequent accelerated rejection 
of BALB/c skin grafts. By contras t, 10,000 BALB/ c ke-
ratinocytes failed to immunize similarly inj ected C3H re-
cipients. These results emphasize the unparalleled capacity 
of Langerh ans cells to induce sensitiza tion, and they point 
to Langerhans cells, among cells within the epidermal com-
partment, as dominant in the alloimmunogenic potential 
of skin grafts . J In vest Derma/o! 89:607- 610, 1987 
erhans cells arc tho ught to playa cemral role in the ea rliest, C lass 
II MH C -dependent phases of antigen recogniti on w ithin the skin . 
Purifi ca tion of epidermal Langerh ans cell s using Au o rescence-
activated cell sorting has recentl y been acco mpli shed usin g m ouse 
skin as a cellular source [11] . When virtuall y pure Langerh ans 
cells are hapten-derivati zed and inocul ated intra veno usly into na-
ive mi ce, they indu ce a state of specifi c contact hypersensitivity 
[12] . By co ntras t, similarl y pu re preparati ons ofkera tin ocytes th at 
have been hapten-derivatized and inocul ated intraveno usly fai l to 
induce sensitivity . M oreover , the efficiency with whi ch pure 
Langerhans cells ca n sens itize fol lowing intravenous inocul ation 
is ex tra ordinary; as few as 6000 haptenated Langerhans cells arc 
suffi cient. For co mpari son , 10,000 hap ten-derivatized kerat ino-
cy tes, and even 50,000 hapten-deri vatized spleen cel ls, fa il to sen-
sitize w hen inj ected intravenously. In fac t, onl y Langerhans cells 
and splenic dendriti c cell s among lymph o reticul ar cells tested to 
date arc able to produce up-regulation of immune responses w hen 
hapten-derivatized and inj ected intraveno usly; other types oflym-
pho reticular cells, as w ell as epitheli al cell s, either fa il to have any 
effect, or induce do w n-regul at ion [1 3,14]. 
A ro le for Lan gerh ans cells as criti cal antigen presentin g cell s 
in induction o f all oimmunity evoked by skin grafts has been 
pro posed [3,4, 15] . In light o f o ur experience w ith the eli citati on 
o f contact hy persensitivity followin g the inoculatio n of hapten-
derivatized purifi ed Langerhans cells, it see m ed appropriate to 
determine w heth er epiderm al Langerhans cells mig ht also be es-
peciall y efficient at inducin g allo immunity, in compariso n to their 
epiderm al co mpanions , keratin ocytes. T he res ults of th e studies 
reported in this communica tio n that exa min e this point confirm 
the special effectiven ess of Langerhans cells in all oa nti gen 
presen ta tion . 
MATERIALS AND M ETH ODS 
Animals Inbred C3H / H eN (1-l-2K) and BALB/ c (H-2D) mice 
were o btained from our breed ing colony at the University of 
Miami School of M ed icine. All anim als were 8- 20 weeks o ld at 
the commencement of the stud y. Recipient an ima ls we re m ales 
in all cases to avoid H-Y sens itiza tio n durin g g raftin g. 
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Media Hank 's balanced sa lt solution (H BSS) suppl emented w ith 
10% hea t inacti vated feta l ca lf serum (FCS) and D NAse (0.01 
mg/ml ) was used in th e initial preparation of Langerh ans cell s 
and kera tin ocytes, except as no ted . For monoclonal antibody 
staining and FA C S sepa ration, phosphate-buffered · sa line (PBS) 
w ith 0.5% FCS and 0.01 m.g/ ml DNA se was used. Spleen cell 
suspensions were prepared in H BSS. All cell s were resuspended 
in PBS, 0.5% FCS and 0.01 mg/ml DNAse prio r to inoculati on. 
Monoclonal Antibody Staining Among th e cells of murine 
epidermis th at are ca pable o f parti cipatin g in an immunologica ll y 
relevant way fo llowing intravenous inocul ation arc Langerhans 
cells, keratinocy tes, and epidermal dendriti c Thy-l bea rin g cells 
[1 2-14J. T he las t are la negative, bone marrow-derived cell s, 
w hi ch appear to have natural killer cell-li ke fun ction w hen cul-
tured in vitro and to display down-regul ating acti vity in vivo 
[1 2, 16-1 8J. Reagents used in th ese ex perim ents to determine the 
immuno logic phenotype o f the prepared cell po pulations we re 
murine anti- lad monoclonal antibody (Becton-Dickinson 1 : 100), 
fl ourescein-conjugated anti-Thy 1.2 (N EN , 1 : 500), and flu ores-
cein-conju ga ted F(ab)'2 goa t anti- mouse immunoglobulin (Ca p-
pel, 1 :40). Antibodies were titered and used at sa turating con-
diti ons. Fifty microliters of antibody was used to stain 106 viable 
cells. Cell s were in cubated on ice fo r 30 min w ith 2 washes be-
tween primary and second ary stains. T he cells w ere incubated 
with the second antibod y for 30 min on ice, then washed 3 times 
before analysis o r separation. 
Preparation of Cell Populations 
Lallgerli ll 11 s Cells: Methods for o btaining enriched la + EC have 
been prev iously described [11] . Briefl y, we incubated shaved, 
trimmed BALB/c pelts in 0.25% trypsin / PBS overnight at 4°C 
to achieve epidermal-derm al separation. Epidermal sheets were 
reincubated in fresh trypsin w ith PBS and DNAse (0. 1 mg/ml) 
to fo rm single cell suspensions. T he resulting suspension was 
filtered th ro ug h Nytex ga uze (1 00 micron mesh) and centrifuged 
over Ficoll-H y paque (density 1.077 g/ml) to enrich fo r bone mar-
row-deri ved cells. The recovered band of cells at th e Ficoll-medi a 
interface was collected , was hed and stained with a murine anti-
lad monocionaJ antibody followed by a flu orescein-conju ga ted 
F(ab) '2 goat anti-mouse immunoglobuJin and sorted using a Coulter 
E PICS V or Becton-Dickinson FACS II . T he resulting population 
of predominantly lad positive cells is referred to subsequ entl y as 
Langerhans cells. 
Comea/ Epithelial Cells: T o prepare single cell suspensions of 
central corn eal epithelium , we excised central corneas from nor-
mal-appearing 6-to 12- week-old BALB/c donors, takin g care to 
avoid the limbus. Ten to 16 co rn ea l buttons were incubated in 
10 ml of l mg/ml D ispase/HBSS for 60 min at 37°C, after which 
the corneal epithelium was removed. Epithelial sheets were gently 
agitated fo r 5 min at room temperature in 5 ml fresh trypsin / PBS 
and the trypsin inhibited by the addition of5 ml m edia containing 
10% FCS. The res ulting cell suspension was filtered through 
N ytex gauze (J O JLm mesh), washed, and resuspended in PBS/0.5% 
FCS/DNAse (0.01 mg/ml) before inoculati on . U sing this tech-
nique, we routinely obtained 5000 to 9000 cells per corn ea with 
greater than 90% viability. Aliquo ts of prepared cells were stained 
indirectl y w ith anti-l ad and directly w ith anti-Thy 1.2 monoclonal 
antibodies and their phenotype determin ed. The resulting cell s 
f.1 iled to express either lad or Thy 1.2 and are referred to subse-
qu entl y as kera tin ocy tes . 
Spleen Cells: Spleens were removed from BALB/c donors, placed 
in HBSS, and gently teased to yield a single cell suspension. The 
supern atant was decanted, and the cells was hed twice and trea ted 
with Tris ammonium chlo ride (0. 16M) to lyse red blood cell s. 
After washing, the cell s were exposed to ga mma irradiation . T he 
cells were washed aga in and res uspended in PBS/O.5% FCS and 
DNAse (0.01 m g/ ml) before inoculation . 
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Erythrocytes: Syngeneic red blood cells (RBC) were used in cell 
suspensions containing fewe r than 10,000 cell s/ml to prevent set-
tlin g o f th e all ogeneic donor cells during manipulati ons. C3H 
peripheral blood was obtained by re troo rbital pun cture, the cell s 
were centrifuged and serum and buffy coa t disca rd ed. T he RBC 
were washed, diluted, and added to allogeneic cell sll spensions 
immediatel y befo re inocul ation to yield a final cell suspension of 
10,000 cell s/m!. 
Sensitization With Allogeneic Cell Suspensions Panels of 
age-m atched C3H males were inoculated intraveno usly w ith 0. 1 
ml of varying doses o f Langerhans cell s, keratinocytes, spleen 
cell s, or media alone. The doses o f nuclea ted cells given ranged 
fro m 10 to 10,000 per inoculati on. Washed C3H RB C were added 
to epidermal cell suspensions containing less th an 10,000 cells/ml 
to yield a fin al concentration of 10,000 cells/ml in the lowes t 
allogeneic doses tested. 
Skin Grafting and Determination of Sensitization Fourteen 
days after intravenous inoculation of allogeneic cells, C3H recip-
ients were an esth etized with atropine and ether and grafted on 
th e th oracic cage w ith BALB/c g rafts, prepared fro m tail skin as 
described previously [1 9]. T he g rafts were imm obili zed with pet-
rolatum ga uze dressin gs and plas ter of paris cas ts. T he animals 
we re un casted 0 11 the seventh day post g raftin g and inspected 
dail y; rej ection was considered to be complete when all epithelium 
was destroyed. 
Median survi val time (MST) o f skin grafts fo r each trea tment 
group was determined. Stati stica l signifi can ce was determined by 
calculating th e 95% confidence limits as determined by the 
no mographs of Lichtfield [20J. 
RESULTS 
The experimental pl an was to prepare purifi ed Langerhans celJs 
(defin ed as la + epiderm al cells) and keratin ocy tes (defi ned as 
co rn eal epithelial cell s) from BALB/c mice. Defin ed numbers of 
cells were then injected intravenously into naive C3H mice w hich 
were chall enged 14 days later w ith an ortho topi c BALB/c skin 
gra ft . T he medi an survival time of these tes t g rafts was taken as 
a meas ure of w heth er the initial inoculation o f cells' had induced 
a state of specifi c sensiti za ti on. It was anti cipated th at animals 
sensitized by pretrea tm ent with a single inocul ati on o f an allo-
geneic epidermal cell preparation would di splay accelerated tes t 
skin graft rejection. 
Characterization of Epidermal Suspensions Used for Intra-
venous Immunization Cell suspensions used as Langerhans 
cells were prepared by density gradient centrifuga tion of tryp-
sinized BALBlc epidermis, fo ll owed by sorting on a flo w cy-
to meter using a monoclonal anti- lad antibody . Cell suspensions 
used as keratinocytes were prepared by trypsiniza tion of central 
corneal epithelium. The resulting cell suspensions were charac-
terized acco rding to cell surface phenotype as depicted in Table 
I. T he Langerhans celJ preparati ons conta ined 85-92% lad + cells. 
The remaining cells have been shown by electron microscopy to 
contain keratin fibers typical o f keratin ocy tes (11). The kerati-
nocyte cell preparation derived from cornea comprised essentiall y 
lad- , Thy 1.2 - cells , although these suspensions did contain up 
to 2% lad + cells. Signifi cant numbers of epidermal dendriti c Thy 
1.2 bea rin g cell s were no t present in either the Langerhans cell 
o r keratinocyte p reparations; their fun ction, if any, in the induc-
tion of allo immunity remains to be determined . 
Table 1. Phenotype of Prepared Epiderm al Cell Populations 
Lall gerhalls cell s 
Keratillocytes 
13"+ 
85-92% 
0.9-2% 
Th y 1. 2+ 
1% 
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Table II. Median Survival Times (M ST) of Heteroto pic 
BALB/c Skin Grafts on C3H Recipients 
MST 
(95% Confidence Limits) Range 
P retreatment N (Days) (Days) 
None (Contro l) 45 11. 6 (10.9-12.3) 9-16 
1,000 la+ Ec 14 9.8 (9.2-10.5)* 9-13 
100 la+ EC 10 10. 1 (9.7-10.5)* 9-1 3 
10 la+ Ec 10 10.5 (9.9-11 .1) 9-15 
10,000 CEC 9 10.2 (9. 1-11.5) 10-12 
1,000 CEC 15 10.8 (10.0-11.6) 9-15 
10,000 SpC 5 10.2 (9.5-11.0)* 10-1 2 
*Thesc va lues arc sign ifica ntly different from the first set co ntro l and indicate 
specific sensitizat ion . 
Ja + EC, la- positive epidermal cells; CEC, co rneal epi thel ial cells; SpC, spleen 
ceUs; N , Number of mice grafted. 
Epidermal Cell Induction of Alloimmunity The capacities 
of epidermal cell suspensions to induce alloimmunity, as evidence 
by the expression of accel~rated skin allograft rejection, was then 
examined . Graded numbers ofBALB/c Langerhans cells (10, 100, 
1000) and keratinocytes (1000, 10,000) were inocul ated intrave-
nously into ad ult C3H mice . As positive controls, 10,000 BALB/c 
spleen cells were sim.ilarly injected intravenously. Two weeks 
later, each mouse received an orthotopic BALB/c skin allograft. 
Dressings were removed 7 days later, and grafts inspected daily 
thereafter until rejection was complete. The results are presented 
in Table II. The median survival time of first set BALB/c skin 
grafts on normal C3H mice is 11.6 days (10.9-1 2.3 = 95% con-
fidence limits). Deliberately sensiti zed C3H mice (recipients of 
10,000 BALB/c spleen cells intravenously) showed a second set 
response of 10.2 days (9.5-11.0 = 95% confid ence limits). This 
difference between first and second set rej ection tim es is highl y 
signifi cant. Two groups of mice displayed median survival times 
w ith 95% confidence limits signifi cantl y shorter than first set 
controls: those that received 100 and 1000 Langerhans cells. We 
take this as evidence of specific sensitization induced by these 
allogeneic Langerhans cell inocula. 
The median surviva l times of BALB/c grafts placed on recip-
ien ts of keratinocytes were somewhat shorter than that of first 
set controls, but not signifi cantl y so. In addition, the shortened 
surviva l time (compared with control) of grafts placed on recip-
ients of 10 Langerh ans cells barely failed to reach statis tical sig-
nificance . We conclude that at limiting doses, Langerhans cells 
are at least 10 and more probably 100-1000 times more efficient 
than keratinocytes at inducing alloimmunity. 
DISCUSSION 
Now that it is technically possible to obtain reasonably pure prep-
ara tions of each of the morphologica ll y unique cell types that 
populate mam malian epidermis, we can begin to describe with 
greater precision the respective, unique functional properties of 
these cells. Viewed in this context, the find ing that Langerhans 
cells are 10 to 100 times more effective than keratinocytes at 
inducing alloimmunity when injected intravenously into naive, 
adult mice has particular signi fi cance. On the basis of numerous 
in v it ro and in vivo studies, there is general agreemen t that Lang-
erh ans cells possess special capacities b r antigen presentation, 
including the constitutive production and expression of C lass II 
histocompatibility determinants [1-3 ,6-10,21]. By contrast, ke-
ratinocytes are thought to perform antigen presenting functions 
only under highly specialized circumstances, if at all [6]. Thus , 
Our findings not only confirm the contrast ing antigen presenting 
potentials of these two epidermal cell types, but provide a semi-
quantitative measure of that difference. These observa tions are 
consistent with the hypothesis that Langerhans cells playa dom-
inant, if not exclusive, role in the allo immunizing capaci ty of 
orthotopic skin grafts. 
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Under normal circumstances, Class II MHC molecules are con-
stitutivel y expressed on Langerhans cell s, but not on keratino-
cytes. Within the past year, it has been reported that the expression 
of C lass I MHC molecules is extremel y low on Langerhans cells, 
but high on keratinocytes [22]. T hus, we presume that the pure 
populations of Langerhans cells and keratinocy tes used in our 
study expressed predominately Class II and C lass [ MHC mol-
ecu les, respectively, with little overl ap . Since the BALB/c and 
C3H mouse strains used in this study are disparate fo r both C lass 
I and C lass II MH C loci, an alterna tive interpretation of our results 
cou ld be that C lass II all oantigens are more efficient/ important 
in skin graft rejection than are C lass [ alloantigens . Such an inter-
pretation is consistent with the view that delayed hypersensitivity, 
rather than cytotoxic T cells, dominate the acute rejection process 
[23]. This domination cannot be absolute, however, since C lass 
I MHC on ly disparate grafts , which lack Langerhans cells (central 
cornea), induce vigorous alloimmunity [9] . We favo r the inter-
pretation that the superiority of Langerhans cells at inducing al-
losensitization originates in their unique functional properties, 
rather than solely with the array of surface alloantigens they express. 
Although constitutively expressed C lass II MHC alloantigens 
can be recogni zed directl y by and thereby lead to the activation 
of specific CD4-bearin g T lymphocytes, C lass I ant igens ex-
pressed on cells that lack C lass II molecules (such as normal ke-
ratinocytes) are usuall y expected to activate C lass I-recognizing, 
CD8-bearing T cells. Experimenta l evidence suggests that durin g 
the induction of alloimmunity, C lass I molecules may fi rst need 
to be reprocessed by Class II MHC- bea ring, antigen presenting 
cell s [24]. When this cond ition is met, helper cell dependent ac-
tivation of C lass I anti gen-recognizing, CD8-bearing T cells ca n 
proceed. We suspect that it is this difference that accounts in part 
for the superior efficiency of Langerhans cells as compared with 
keratinocytes in the induction of skin allograft immunity. 
The conclusion that only 100 allogeneic Langerhans cells are 
needed to sensitize an adult mouse is remarkable from another 
standpoint. Over the past two and a half decades of transplan-
tation research, several stud ies have examined the minimum num-
ber of cells or size of tissue that is sufficient to induce alloim-
munity. T he experimental protocol used in these previous studies 
was to inocu late cells or implant tissue from inbred , fully allo-
geneic mouse strains in to naive recipients, graft recipients with 
donor skin, and measure skin graft survival times . In 1957, Bil-
lingham and associates [25] demonstrated that the intraperitoneal 
inoculation of 10,000 allogeneic spleen cells sensitized recipients, 
lead ing to accelera ted skin graft rejection , w hereas the inocu lation 
of 2000 spleen cells fa iled to sensitize. Barnes [26] examined the 
effect of implanting various allogeneic tissues, either subcutane-
ously or intramuscularly, in inbred mouse strains on subsequent 
donor graft survival. The implantation of 0.5 mg of skin primed 
recipients, resulting in accelerated graft reject ion. The precise 
number of cells, and components of the grafts that Barnes im-
planted are unknown; however, it is reasonable to assume that 
the inoculum contained greater than 10,000 cells, and included 
both dermal and epidermal components. Finally, in 1973, Floer-
sheim [27] injected 1000 cells obtai ned from either bone marrow 
or thymus intravenously in to allogeneic recipients and elicited 
accelerated graft rejection . Until this report, 1000 bone marrow 
derived cells or th ymocytes were judged to be the minimum 
requirement for allosensitization in this system. It is now clea r 
than ten-fold fewer Langerhans cells can accomplish the same 
end. 
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